Data Foundry

Drug recalls 2013

LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS — Class II drug recall D-244-2013

Terminated recall by Gsms, reported 2013-04-17, distributed nationwide. Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were

Recall numberD-244-2013
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmGsms, Camarillo, CA, United States
Recall initiated2013-03-11
Classified2013-04-07
Reported by FDA2013-04-17
Terminated2013-09-03
DistributedNationwide (US)
Quantity6,158 bottles
Reason classesspecification failure
NDC60429-0046-01, 60429-0046-10
Lot numbers60429-046-01, 60429-046-1, 60429-046-10, 69393A1, 69395A1, 69495A1, 69496A1, 69497A1, 69524A1, 69524A2, 69525A1, 69525A2

Product

LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS, USP, 20 mg/25 mg, 100 (NDC 60429-046-01) and 1,000 (NDC 60429-046-10) count bottles, Rx only, GSMS Inc., Camarillo, CA

Reason for recall

Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-244-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.